1. Home
  2. SYBX vs STFS Comparison

SYBX vs STFS Comparison

Compare SYBX & STFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • STFS
  • Stock Information
  • Founded
  • SYBX N/A
  • STFS 2015
  • Country
  • SYBX United States
  • STFS China
  • Employees
  • SYBX N/A
  • STFS N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • STFS
  • Sector
  • SYBX Health Care
  • STFS
  • Exchange
  • SYBX Nasdaq
  • STFS NYSE
  • Market Cap
  • SYBX 13.6M
  • STFS 11.9M
  • IPO Year
  • SYBX N/A
  • STFS 2024
  • Fundamental
  • Price
  • SYBX $1.07
  • STFS $1.22
  • Analyst Decision
  • SYBX
  • STFS
  • Analyst Count
  • SYBX 0
  • STFS 0
  • Target Price
  • SYBX N/A
  • STFS N/A
  • AVG Volume (30 Days)
  • SYBX 11.1K
  • STFS 267.9K
  • Earning Date
  • SYBX 05-20-2025
  • STFS 02-14-2025
  • Dividend Yield
  • SYBX N/A
  • STFS N/A
  • EPS Growth
  • SYBX N/A
  • STFS 43.38
  • EPS
  • SYBX 0.21
  • STFS 0.15
  • Revenue
  • SYBX N/A
  • STFS $14,972,726.00
  • Revenue This Year
  • SYBX N/A
  • STFS N/A
  • Revenue Next Year
  • SYBX N/A
  • STFS N/A
  • P/E Ratio
  • SYBX $5.25
  • STFS $8.23
  • Revenue Growth
  • SYBX N/A
  • STFS 57.60
  • 52 Week Low
  • SYBX $0.90
  • STFS $0.80
  • 52 Week High
  • SYBX $1.91
  • STFS $17.91
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 45.73
  • STFS N/A
  • Support Level
  • SYBX $1.00
  • STFS N/A
  • Resistance Level
  • SYBX $1.19
  • STFS N/A
  • Average True Range (ATR)
  • SYBX 0.09
  • STFS 0.00
  • MACD
  • SYBX 0.00
  • STFS 0.00
  • Stochastic Oscillator
  • SYBX 55.00
  • STFS 0.00

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About STFS STAR FASHION CULTURE HOLDINGS LIMITED

Star Fashion Culture Holdings Ltd is a content marketing solutions services provider. The company offer services focusing on marketing campaign planning and execution, offline advertising services; and online precision marketing services. The services also include marketing campaign planning and execution, events including marathons, sports events, and music festivals.

Share on Social Networks: